[article] 
inJournal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3063-3071

Titre :	Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder
Type de document :	Texte imprimé et/ou numérique
Auteurs :	Tara R. BUCK, Auteur ; Joseph VISKOCHIL, Auteur ; Megan FARLEY, Auteur ; Hilary COON, Auteur ; William M. MCMAHON, Auteur ; Jubel MORGAN, Auteur ; Deborah A. BILDER, Auteur
Article en page(s) :	p.3063-3071
Langues :	Anglais (eng)
Mots-clés :	Autism spectrum disorder  Psychiatric comorbidity  Psychotropic medication  Intellectual disability
Index. décimale :	PER Périodiques
Résumé :	The purpose of this study was to investigate comorbid psychiatric disorders and psychotropic medication use among adults with autism spectrum disorder (ASD) ascertained as children during a 1980’s statewide Utah autism prevalence study (n = 129). Seventy-three individuals (56.6 %) met criteria for a current psychiatric disorder; 89 participants (69.0 %) met lifetime criteria for a psychiatric disorder. Caregivers reported a psychiatric diagnosis in 44 participants (34.1 %). Anxiety disorder had the highest current and lifetime prevalence (39.5 and 52.7 %, respectively). Participants with intellectual disability (n = 94, 72.8 %) were significantly less likely to have community-based diagnoses of anxiety (?2 = 5.37, p = 0.02) or depression (?2 = 13.18, p 0.001) reported by caregivers. Seventy-six participants (58.9 %) were taking ?1 psychotropic medication. Comorbid psychiatric disorders occur frequently in adults with ASD, though identifying these disorders poses a challenge in community settings. A greater understanding of the presentation of these conditions within this population will increase assessment validity and the potential for efficacious intervention.
En ligne :	http://dx.doi.org/10.1007/s10803-014-2170-2
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243

[article] Psychiatric Comorbidity and Medication Use in Adults with Autism Spectrum Disorder [Texte imprimé et/ou numérique] / Tara R. BUCK, Auteur ; Joseph VISKOCHIL, Auteur ; Megan FARLEY, Auteur ; Hilary COON, Auteur ; William M. MCMAHON, Auteur ; Jubel MORGAN, Auteur ; Deborah A. BILDER, Auteur . - p.3063-3071.
Langues : Anglais (eng)
in Journal of Autism and Developmental Disorders > 44-12 (December 2014) . - p.3063-3071

Mots-clés :	Autism spectrum disorder  Psychiatric comorbidity  Psychotropic medication  Intellectual disability
Index. décimale :	PER Périodiques
Résumé :	The purpose of this study was to investigate comorbid psychiatric disorders and psychotropic medication use among adults with autism spectrum disorder (ASD) ascertained as children during a 1980’s statewide Utah autism prevalence study (n = 129). Seventy-three individuals (56.6 %) met criteria for a current psychiatric disorder; 89 participants (69.0 %) met lifetime criteria for a psychiatric disorder. Caregivers reported a psychiatric diagnosis in 44 participants (34.1 %). Anxiety disorder had the highest current and lifetime prevalence (39.5 and 52.7 %, respectively). Participants with intellectual disability (n = 94, 72.8 %) were significantly less likely to have community-based diagnoses of anxiety (?2 = 5.37, p = 0.02) or depression (?2 = 13.18, p 0.001) reported by caregivers. Seventy-six participants (58.9 %) were taking ?1 psychotropic medication. Comorbid psychiatric disorders occur frequently in adults with ASD, though identifying these disorders poses a challenge in community settings. A greater understanding of the presentation of these conditions within this population will increase assessment validity and the potential for efficacious intervention.
En ligne :	http://dx.doi.org/10.1007/s10803-014-2170-2
Permalink :	https://www.cra-rhone-alpes.org/cid/opac_css/index.php?lvl=notice_display&id=243